139 related articles for article (PubMed ID: 31378211)
21. Noonan syndrome: structural abnormalities of the mitral valve causing subaortic obstruction.
Marino B; Gagliardi MG; Digilio MC; Polletta B; Grazioli S; Agostino D; Giannotti A; Dallapiccola B
Eur J Pediatr; 1995 Dec; 154(12):949-52. PubMed ID: 8801101
[TBL] [Abstract][Full Text] [Related]
22. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
[TBL] [Abstract][Full Text] [Related]
23. Asymmetric septal hypertrophy and propranolol treatment in a case of Ullrich-Noonan syndrome.
Jackson G; Anand IS; Oram S
Br Heart J; 1979 Nov; 42(5):611-4. PubMed ID: 518788
[TBL] [Abstract][Full Text] [Related]
24. [Hypertrophic cardiomyopathy in 2013].
Giannakopoulos G; Frangos C
Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
[TBL] [Abstract][Full Text] [Related]
25. Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: Left main coronary artery atresia causing sudden death.
Ramond F; Duband S; Croisille P; Cavé H; Teyssier G; Adouard V; Touraine R
Eur J Med Genet; 2017 Jun; 60(6):299-302. PubMed ID: 28347726
[TBL] [Abstract][Full Text] [Related]
26. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients.
Burch M; Sharland M; Shinebourne E; Smith G; Patton M; McKenna W
J Am Coll Cardiol; 1993 Oct; 22(4):1189-92. PubMed ID: 8409059
[TBL] [Abstract][Full Text] [Related]
27. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA
Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043
[TBL] [Abstract][Full Text] [Related]
28. Causes of sudden cardiac arrest in young athletes.
Westrol MS; Kapitanyan R; Marques-Baptista A; Merlin MA
Postgrad Med; 2010 Jul; 122(4):144-57. PubMed ID: 20675977
[TBL] [Abstract][Full Text] [Related]
29. Biventricular hypertrophic cardiomyopathy with right ventricular outflow tract obstruction associated with Noonan syndrome in an adult.
Hayashi S; Tojyo K; Uchikawa S; Momose T; Misawa T; Yazaki Y; Kinoshita O; Hongo M; Kubo K; Imamura H
Jpn Circ J; 2001 Feb; 65(2):132-5. PubMed ID: 11216824
[TBL] [Abstract][Full Text] [Related]
30. Proximal left coronary artery occlusion in a 15-year-old boy with noonan syndrome and hypertrophic cardiomyopathy.
Delhaas T; Mühler EG
Pediatr Cardiol; 2003; 24(1):67-9. PubMed ID: 12574982
[TBL] [Abstract][Full Text] [Related]
31. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
[TBL] [Abstract][Full Text] [Related]
32. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
[TBL] [Abstract][Full Text] [Related]
33. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and Reliability of Nonexpert POCUS for Cardiovascular Preparticipation Screening of Varsity Athletes: The SHARP Protocol.
Moulson N; Jaff Z; Wiltshire V; Taylor T; O'Connor HM; Hopman WM; Johri AM
Can J Cardiol; 2019 Jan; 35(1):35-41. PubMed ID: 30595181
[TBL] [Abstract][Full Text] [Related]
35. [Cooley operation for hypertrophic obstructive cardiomyopathy associated with Noonan Syndrome following Morrow operation--a case report].
Takeda Y; Suzuki Y; Mishima A; Narita Y; Yamanaka Y; Yoshitomi H
Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):574-9. PubMed ID: 8035080
[TBL] [Abstract][Full Text] [Related]
36. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV
Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Norrish G; Cantarutti N; Pissaridou E; Ridout DA; Limongelli G; Elliott PM; Kaski JP
Eur J Prev Cardiol; 2017 Jul; 24(11):1220-1230. PubMed ID: 28482693
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric septal hypertrophy in a 41-year-old woman with Noonan's syndrome.
Doyama K; Hirose K; Fujiwara H
Chest; 1990 Jun; 97(6):1480-1. PubMed ID: 2347236
[TBL] [Abstract][Full Text] [Related]
39. Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes.
Wilmshurst PT; Katritsis D
Heart; 1996 Jan; 75(1):94-7. PubMed ID: 8624883
[TBL] [Abstract][Full Text] [Related]
40. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
